-
Sirona Announces $100M Share Repurchase Authorization
Monday, August 22, 2011 - 5:33pm | 162Sirona (NASDAQ: SIRO) today announced that the Company`s Board of Directors has authorized the repurchase of up to $100 million of the Company`s common stock. Jost Fischer, Chairman and CEO of Sirona commented: "The initiation of the share repurchase program reflects our confidence in the...
-
Wunderlich Maintains Buy on Medtronic
Monday, August 22, 2011 - 7:48am | 127Wunderlich is out with its report today on Medtronic (NYSE: MDT), maintaining Buy. In its report, Wunderlich writes, "We believe fiscal 2012 guidance was set conservatively back in May, a common courtesy to an incoming CEO, though MDT's operating environment has only gotten more difficult since...
-
Benzinga's Top Pre-Market Gainers
Monday, August 22, 2011 - 7:44am | 111Boston Scientific Corporation (NYSE: BSX) shares advanced 12.42% to $6.88 in the pre-market session. BSX's trailing-twelve-month revenue is $7.82 billion. Corning Incorporated (NYSE: GLW) shares advanced 6.91% to $15.31 in the pre-market session. GLW's PEG ratio is 0.69. Regions Financial...
-
Morgan Keegan Reiterates Outperform on Edwards Lifesciences
Monday, August 22, 2011 - 7:37am | 94Morgan Keegan is out with its report today on Edwards Lifesciences (NYSE: EW), reiterating Outperform. In its report, Morgan Keegan writes, "We are reiterating our Outperform rating for Edwards Lifesciences after reevaluating its percutaneous valve market opportunity and the risk to the number of...
-
A Peek Into The Market Before The Trading Starts
Monday, August 22, 2011 - 7:29am | 380Pre-open movers US stock futures are higher this morning. Futures on the Dow Jones Industrial Average surged 102 points to 10,922.00 and futures on the S&P 500 stock index rose 12.70 points to 1,136.20. Nasdaq 100 futures gained 27.75 points to 2,068.75. A Peek Into Global Markets Asian...
-
Delcath Announces Encouraging Top-Line Results From Hepatobiliary Cohort in Phase II Trial of Chemosaturation System
Monday, August 22, 2011 - 6:38am | 146Delcath Systems, Inc. (NASDAQ: DCTH) reported encouraging top-line results from the hepatobiliary cohort of the Phase II clinical trial of the Delcath chemosaturation system with melphalan in the treatment of patients with unresectable liver cancer. This study, conducted at the National Cancer...
-
Kinetic Concepts Gets Bid from ConvaTec -Bloomberg
Sunday, August 21, 2011 - 9:46pm | 96Kinetic Concepts (NYSE: KCI), which agreed last month to a $5 billion or $68.50 per share leveraged buyout by Apax Partners, a London-based private equity firm, and two Canadian pension funds, has apparently received a higher offer from competitor ConvaTec, according to sources. The offer came just...
-
Notable Call Options Activity in MAKO Surgical
Friday, August 19, 2011 - 2:40pm | 86Shares of MAKO Surgical (NASDAQ: MAKO) are higher on the session by 2.56%, currently trading at $30.40. The stock has been moving largely higher over the past six months and is currently trading above at the 200-day average. Options traders are focusing on calls today. A short while ago the...
-
Duncan Williams Raises Kensey Nash PT, Maintains Buy
Friday, August 19, 2011 - 1:18pm | 103Duncan Williams raised its Kensey Nash (NASDAQ: KNSY) price target from $31 to $32 and maintained its Kensey Nash Buy rating in a research report published today. In the report, Duncan Williams states, "We believe that KNSY will receive $6.0 million in milestone payments in fiscal 2012. In terms...
-
Pre-Market Losers; Cincinnati Bell Down 13%
Friday, August 19, 2011 - 9:23am | 113Cincinnati Bell (NYSE: CBB) -13.18% Aeropostale (NYSE: ARO) -12.97% on disappointing same store sales data. Nordson Corporation (NASDAQ: NDSN) -10.39% on disappointing earnings and guidance. DexCom (NASDAQ: DXCM) -8.94% on heavy volume. Advantage Oil & Gas (NYSE: AAV) -8.93% on heavy...
-
UPDATE: Duncan-Williams Raises PT on Kensey Nash to $32
Friday, August 19, 2011 - 8:41am | 61Duncan-Williams is out with its report today on Kensey Nash (NASDAQ: KNSY), raising its PT to $32 from $31. In its report, Duncan-Williams writes, "We are maintaining our BUY rating and are raising our twelve month price target to $32.00 from $31.00. This represents approximately 17 times our...
-
Morgan Stanley Previews F1Q12 at Medtronic
Friday, August 19, 2011 - 7:41am | 82Morgan Stanley has published a research report on Medtronic Inc (NYSE: MDT). In the report, Morgan Stanley wrote, "Consensus EPS of $0.79 (MS of $0.80) and revenue of $3.98bn (MS of $4.02mn) seem achievable. Our CRM numbers are likely adequately conservative but our Spine numbers, specifically...
-
Invacare Corporation Board of Directors Authorizes the Extension of Share Repurchase Program
Thursday, August 18, 2011 - 6:04pm | 102Invacare (NYSE: IVC) today announced that its board of directors authorized the Company to repurchase additional outstanding Company common shares, bringing its overall share repurchase authorization up to 2,500,000 common shares as of the August 17, 2011, board meeting. The authorization has no...
-
Stryker Appoints Ramesh Subrahmanian to Group President, International
Thursday, August 18, 2011 - 4:27pm | 179Stryker Corporation (NYSE: SYK) announced today the appointment of Ramesh Subrahmanian to the role of Group President, International, effective September 1, 2011. This role was formerly held by Andrew Fox-Smith, who is leaving Stryker to pursue other career opportunities. Subrahmanian will report...
-
UPDATE: Stifel Nicolaus Initiates Integra LifeSciences Holdings at Hold
Thursday, August 18, 2011 - 9:13am | 96Stifel Nicolaus is out with its report today on Integra LifeSciences Holdings (NASDAQ: IART), initiating IART at Hold. In its report, Stifel Nicolaus writes, "Following extensive M&A activity in recent years to move Integra into faster-growth and higher-margin Orthopedic businesses (...